NeoGenomics

美股公司 · 2018年11月27日 · 32 次阅读

NeoGenomics, Inc., together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories in the United States. It operates through Clinical Services and Pharma Services segments. The company laboratories provide genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, pharmaceutical firms, and other clinical laboratories. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services that focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level. The company also provides pathology consultation services for clients in which its pathologists review surgical samples on a consultative basis; and testing services in support of its pharmaceutical clients' oncology programs, as well as acts as a reference laboratory supplying anatomic pathology testing services. The company has a strategic alliance with Pharmaceutical Product Development Inc. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

公司基本面

市值 15.0亿 市盈率 322.94
当前价 16.30 目标价 20.71
ROI 0.70% ROE 3.90%
ROA 2.10% RSI 50.76
指标说明
市盈率 = 股价/年度每股收益:
  • <0 :指该公司盈利为负(计算市盈率没有意义,一般显示为“—”)
  • 0-13 :即价值被低估(一般传统行业 或者周期性行业的股票都比较低 比如美光科技)
  • 14-20:即正常水平
  • 21-28:即价值被高估
  • 28+ :反映股市出现投机性泡沫
市净率 = 总市值/所有者权益:

一般市净率较低的股票, 投资价值较高

资产收益率(ROA) = 净利润/总资产:

该指标越高 表示公司资产利用效果越好

净资产收益率(ROE) = 净利润/总股东权益:

该指标越高 表示投资带来的收益越高

NeoGenomics 公司 评级升降级

日期 机构 评级 目标价
18-10-24 First Analysis Sec 升级 跑赢市场 → Strong 购买 $18
18-08-21 Leerink Partners 启动 跑赢市场 $18
18-05-02 First Analysis Sec 降级 强烈建议 → Equal-Weight $11
17-09-11 BTIG Research 降级 购买 → 中立
17-08-24 Gabelli & Co 启动 购买 $9
16-12-15 Cantor Fitzgerald 启动 强烈建议 $11
16-10-04 First Analysis Sec 启动 强烈建议 $11
16-07-27 The Benchmark Company 重申 购买 $10 → $12
16-04-28 The Benchmark Company 重申 购买 $8 → $9
16-03-11 The Benchmark Company 启动 购买 $8
15-10-26 ROTH Capital 购买 $7.50 → $10
15-07-13 ROTH Capital 重申 购买 $7 → $7.50
14-05-14 Dawson James 启动 购买 $6
13-04-25 Ladenburg Thalmann 降级 购买 → 中立
13-02-14 Ladenburg Thalmann 重申 购买 $3.50 → $3.75

相关问题

互联网券商的港股、美股开户教程

如果您对美股 或者 港股也感兴趣, 或者想要了解如何开户, 可以加我wechat: xiaobei060537, 同时也可以拉您进美股交流群哦。
最后的最后 祝大家都有一个美好的投资生活哦。

大家也可以关注美股指南公众号, 会定期更新一些美股知识哦

写在最后

友情提示 转载请注明出处: https://investguider.com/topics/832
暂无回复。
需要 登录 后方可回复, 如果你还没有账号请点击这里 注册